Myasthenia gravis induced by pembrolizumab in a patient with metastatic Merkel cell carcinoma

被引:1
|
作者
Pottier, C. [1 ]
El Habnouni, C. [1 ]
Kervarrec, T. [2 ,3 ]
Beltran, S. [4 ]
Samimi, M. [1 ,3 ]
机构
[1] CHRU Tours, Dept Dermatol, Hosp Trousseau, Ave Republ, F-37044 Tours 9, France
[2] CHRU Tours, Dept Pathol, F-37044 Tours 9, France
[3] Univ Tours, INRA, ISP 1282, F-37000 Tours, France
[4] CHRU Tours, Dept Neurol, F-37044 Tours 9, France
来源
关键词
Myasthenia gravis; Immune checkpoint inhibitors; Pembrolizumab; Immune adverse event;
D O I
10.1016/j.annder.2022.01.002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:142 / 145
页数:4
相关论文
共 50 条
  • [21] Exacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab
    Lau, K. H. Vincent
    Kumar, Aditya
    Yang, Irene Hwa
    Nowak, Richard J.
    MUSCLE & NERVE, 2016, 54 (01) : 157 - 161
  • [22] A CURIOUS CASE OF PEMBROLIZUMAB-INDUCED MYASTHENIA GRAVIS
    Petro, Joseph
    Burak, Nicole
    Bogart, Michael
    Markley, Daniel
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 379 - 379
  • [23] PEMBROLIZUMAB-INDUCED MYOCARDITIS, MYOSITIS, AND MYASTHENIA GRAVIS
    Itmam, Arif
    Sifontes, Erick Perez
    Milligan, Rebecca
    Sarkar, Sujata
    Alnahas, Zeinab
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [24] Treatment of Merkel cell carcinoma with pembrolizumab in a patient with psoriasis and psoriatic arthritis
    Roche, L.
    Murphy, M.
    Power, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 143 - 143
  • [25] Rituximab in the treatment of pembrolizumab-induced myasthenia gravis
    Crusz, S. M.
    Radunovic, A.
    Shepherd, S.
    Shah, S.
    Newey, V.
    Phillips, M.
    Lim, L.
    Powles, T.
    Szlosarek, P. W.
    Shamash, J.
    Rashid, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 102 : 49 - 51
  • [26] Treatment of Merkel cell carcinoma with pembrolizumab in a patient with psoriasis and psoriatic arthritis
    Roche, L.
    Murphy, M.
    Power, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 64 - 64
  • [27] Treatment of merkel cell carcinoma with pembrolizumab in a patient with psoriasis and psoriatic arthritis
    Roche, L.
    Murphy, M.
    Power, D. G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 96 - 96
  • [28] Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab
    Thiem, Alexander
    Kneitz, Hermann
    Schummer, Patrick
    Herz, Stefan
    Schrama, David
    Houben, Roland
    Goebeler, Matthias
    Schilling, Bastian
    Gesierich, Anja
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (10) : 1252 - 1254
  • [29] Development of Merkel Cell Carcinoma and Squamous Cell Carcinoma During Treatment With Pembrolizumab for Metastatic Mucosal Melanoma
    Hajar, Tamar
    Hill, Emma E.
    Leitenberger, Justin J.
    DERMATOLOGIC SURGERY, 2020, 46 (11) : 1443 - 1445
  • [30] Myasthenia Gravis and Myocarditis After Administration of Pembrolizumab in a Patient With Metastatic Non-small Cell Lung Cancer and Resected Thymoma
    Kee, Wanyi
    Ng, Kennedy Yao Yi
    Lee, Joycelyn Jie Xin
    Tan, Daniel Shao Weng
    CLINICAL LUNG CANCER, 2022, 23 (04) : E293 - E295